A significant number of patients are filing compensation claims against manufacturers of the heartburn medication Zantac. Allegations against the drug center around possible links to certaincancers, leading to a wave of claims. The federal government has also phased out the sale of Zantac, heightening concerns about its safety. Law professionals p